Spots Global Cancer Trial Database for gastrointestinal tumors
Every month we try and update this database with for gastrointestinal tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of INCB123667 in Subjects With Advanced Solid Tumors | NCT05238922 | Solid Tumors | INCB0123667 | 18 Years - | Incyte Corporation | |
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors | NCT06152757 | Gastrointestina... | First dose Second dose The third dose The fourth dose | 18 Years - | BioSyngen Pte Ltd | |
Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors | NCT05981235 | Gastrointestina... | AZD6422 CLDN18.... | 18 Years - | Peking University | |
Study of Minnelide™ in Patients With Advanced GI Tumors | NCT01927965 | Advanced Gastro... | Minnelide™ 001 | 18 Years - | Minneamrita Therapeutics LLC | |
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors | NCT06152757 | Gastrointestina... | First dose Second dose The third dose The fourth dose | 18 Years - | BioSyngen Pte Ltd | |
Study of INCB123667 in Subjects With Advanced Solid Tumors | NCT05238922 | Solid Tumors | INCB0123667 | 18 Years - | Incyte Corporation | |
Study of INCB123667 in Subjects With Advanced Solid Tumors | NCT05238922 | Solid Tumors | INCB0123667 | 18 Years - | Incyte Corporation | |
Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal Diseases | NCT06236594 | Gastrointestina... | 18 Years - 80 Years | Beijing 302 Hospital | ||
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors | NCT01640665 | Metastatic Brea... Gastrointestina... | Sorafenib Capecitabine | 18 Years - | Yale University | |
Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors | NCT05922358 | Gastrointestina... | Anti-allergic t... | 18 Years - 75 Years | Fujian Cancer Hospital | |
Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors | NCT06085365 | Gastrointestina... Immunonutrition Postoperative A... | Immunonutrition... fluorouracil ba... | 18 Years - 75 Years | China Medical University, China | |
Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors | NCT05981235 | Gastrointestina... | AZD6422 CLDN18.... | 18 Years - | Peking University | |
Wound Management Following Gl Tumor Surgery: Comparing Outcomes of Dressing Changes Versus Non-Dressing Techniques | NCT06263205 | Gastrointestina... Surgical Wound ... Pain, Postopera... | Non-Dressing of... Regular Dressin... | 18 Years - 75 Years | Fudan University | |
The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies | NCT01552291 | Malnourishment Gastrointestina... | Glutamine Placebo | - | Insel Gruppe AG, University Hospital Bern | |
Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors | NCT01648465 | Gastrointestina... Pancreatic Tumo... Gastrointestina... Pancreatic Neur... | Everolimus | 18 Years - | Hellenic Cooperative Oncology Group | |
Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors | NCT05922358 | Gastrointestina... | Anti-allergic t... | 18 Years - 75 Years | Fujian Cancer Hospital | |
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) | NCT03833700 | Solid Neoplasms Colorectal Neop... Gastrointestina... | E7386 | 18 Years - | Eisai Inc. |